Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA methylation at the MYC locus refers to the addition of methyl groups, typically to cytosine bases in CpG dinucleotides, within or near the genomic region encoding the MYC gene. Aberrant DNA methylation patterns at this locus are implicated in cancer development and progression. Changes in DNA methylation can modulate MYC expression levels, impacting cell growth, proliferation, differentiation, and apoptosis.
Modulation of gene expression through alteration of DNA methylation patterns
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Methylation at the MYC Locus.